However, these results likelyreflected long-term effects of elevated glutamate levels on receptor availability,an interpretation supported by post-mortem tissue evidence that patients with ahistory of depression have reduced mGlu5 protein expression (Deschwanden et al., 2011). The gene discussed is GRM5; the disease is depressive disorder.